实践参数:治疗神经系统莱姆病(一个基于证据的审查):质量标准委员会的报告,美国神经病学学会首页
特别篇“实践参数:治疗神经系统莱姆病(一个基于证据的审查):质量标准委员会的报告,美国神经病学学会,“J.J. Halperin et al。(首页首页®69:91 2007;102),以下的利益冲突声明无意中省略。奥斯卡遗憾的错误。
Halperin博士持有股票在雅培,百时美施贵宝公司,强生公司,先灵葆雅,Vasogen。他曾作为专家证人在医疗事故的行动。夏皮罗博士已经收到审查残疾赔偿基金从大都会人寿保险公司,并担任专家证人在玩忽职守的行为。他还收到了来自默克谢礼,inc .)和安内特演讲。夏皮罗博士收到资金来自国家卫生研究院的基金K24RR022477 KL2RR024138, UL1RR024139。Logigian博士已经Actelion股价药品顾问有限公司,担任专家证人莱姆病在2004年。Belman博士没有披露。Dotevall博士已经收到资金从辉瑞公司讲课。蠕虫博士报告了研究经费与莱姆病来自疾病控制与预防中心、国家卫生研究院,Immunetics, Inc ., BioRad。他是老板Diaspex, LLC公司没有产品或服务。 He has been an expert witness for the United States in a medical malpractice case and has been retained in other medical practice cases involving Lyme disease. Dr. Wormser has overseen educational grants to New York Medical College to support Infectious Diseases grand rounds from Merck and AstraZeneca, and one from Pfizer is expected in 2008. Dr. Krupp has no conflicts of interest to report. Dr. Gronseth holds financial interests in Pfizer and GlaxoSmithKline, has received speaker honoraria from Boeheringer Ingelheim, and has received honoraria from Ortho-McNeil for serving on the IDMC Committee. Dr. Bever has received honoraria from Teva Pharmaceuticals, Berlex Laboratories, Serono, Pfizer, Senofi-Aventis, and Accorda Therapeutics. Dr. Bever has received research funding from Serono and Accorda Therapeutics.
